Lipella Pharmaceuticals I...

NASDAQ: LIPO · Real-Time Price · USD
2.90
-0.09 (-3.01%)
At close: May 23, 2025, 3:59 PM
2.90
0.00%
After-hours: May 23, 2025, 04:59 PM EDT

Lipella Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2022
Grant Revenues Revenue 184.16K
Grant Revenues Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Selling, General, and Administrative Revenue 463.74M 562.62K 493.1K 427.06K 520.93K 395.51K 627.52K 624.23K 508.75K 32.17K 47.55K 45.99K 100.49K 92.64K 45.77K 140.9K 439.07K
Selling, General, and Administrative Revenue Growth +82324.08% +14.10% +15.46% -18.02% +31.71% -36.97% +0.53% +22.70% +1481.59% -32.35% +3.39% -54.23% +8.46% +102.43% -67.52% -67.91% n/a
Research and Development Revenue 993.48M 1.06M 1.05M 661.56K 842.6K 454.2K 833.26M 1.06M 693.73K 478.1K 665.02K 735.23K 669.32K 373.4K 477.14K 347.92K 258.33K
Research and Development Revenue Growth +93417.96% +1.49% +58.22% -21.49% +85.51% -99.95% +78684.47% +52.46% +45.10% -28.11% -9.55% +9.85% +79.25% -21.74% +37.14% +34.68% n/a